India, Jan. 31 -- What are the key objectives of your recent collaboration with Merck? How will this partnership foster innovation and strengthen India's position in the global biotech market?

The partnership combines Merck's biomanufacturing systems with GNG's Clone Development and HIND Antibody Library to drive biopharmaceutical innovation and position India as a hub for advanced R&D. The GNG-Merck collaboration creates a unique competitive edge for both companies by integrating local expertise with global biomanufacturing capabilities. Furthermore, Merck's expertise in both Upstream Processing (USP) and Downstream Processing (DSP) will support us in areas of biologics production, optimising cell culture yields, and refining end produc...